文献速递细菌感染、耐药与抗菌药物医院感染防控

就诊于全科医疗的儿童抗生素处方及严重与非严重感染的时间趋势:一项基于162507人的注册纵向队列研究

Temporal trends in antibiotic prescribing and serious and nonserious infections in children presenting to general practice: a registry-based longitudinal cohort study of 162 507 individuals.
PubMed 文献 · J Antimicrob Chemother · 2024-01-01

该回顾性队列研究利用比利时弗兰德斯INTEGO网络162507名患者数据,分析2002至2022年儿童全科抗生素处方率及感染发病率趋势。抗生素处方率从584/1000人年降至484/1000人年,总体处方比例从46.3%降至23.3%;严重感染处方比例从64.1%升至69.8%,非严重感染处方比例从45.6%降至20.9%。严重和非严重感染发病率分别从34.2/1000人年和785/1000人年升至64.1/1000人年和1223/1000人年。

要点

  • 2002至2022年儿童全科抗生素处方率显著下降,从584/1000人年降至484/1000人年。
  • 严重感染抗生素处方比例从64.1%升至69.8%,非严重感染从45.6%降至20.9%。
  • 肺炎抗生素处方比例从65.2%升至80.2%,而急性化脓性中耳炎从74.7%降至64.1%。

核心结论

  • 2002年至2022年,儿童全科抗生素处方下降,但广谱抗生素使用及中耳炎、支气管炎/细支气管炎的处方仍需针对性管理。

研究设计与样本

  • 回顾性队列研究,使用比利时弗兰德斯INTEGO网络162507名患者数据,按年龄(0-1、2-6、7-12岁)和市镇分层,进行自回归移动平均时间序列分析和季节性分析。

主要发现

  • 抗生素处方率从584/1000人年(95%CI 571-597)降至484/1000人年(95%CI 478-491),总体处方比例从46.3%(95%CI 45.1-47.6)降至23.3%(95%CI 22.9-23.7),其中阿莫西林占59.3%,广谱抗生素占17.8%。
  • 非严重感染处方比例从45.6%降至20.9%,严重感染处方比例从64.1%升至69.8%。
  • 急性化脓性中耳炎处方比例从74.7%降至64.1%,上呼吸道感染从44.9%降至16.6%,支气管炎/细支气管炎从73.6%降至44.1%,急性扁桃体咽炎从59.5%降至21.7%,肺炎从65.2%升至80.2%。
  • 非严重感染发病率从785/1000人年升至1223/1000人年,严重感染发病率从34.2/1000人年升至64.1/1000人年。
  • 血液和CRP检测比例显著增加。

临床怎么用

  • 作者认为需要进一步的针对性抗生素管理举措,以减少广谱抗生素的使用以及中耳炎和支气管炎/细支气管炎的抗生素处方。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is crucial to understand the trends in paediatric antibiotic prescribing and serious and nonserious infections to improve antibiotic prescribing practices for children in ambulatory care. OBJECTIVES: Assessing trends in paediatric antibiotic prescribing and infection incidence in general practice from 2002 to 2022. METHODS: In this retrospective cohort study using INTEGO network data from 162 507 patients in Flanders (Belgium), we calculated antibiotic prescribing rates and proportions alongside incidence rates of serious and nonserious infections, stratified by age (0-1, 2-6, 7-12 years) and municipality. We performed autoregressive moving average time-series analyses and seasonality analyses. RESULTS: From 2002 to 2022, antibiotic prescribing rate decreased significantly: 584/1000 person-years (PY) (95% CI 571-597) to 484/1000PY (95% CI 478-491); so did antibiotic overall prescribing proportion: 46.3% (95% CI 45.1-47.6) to 23.3% (95% CI 22.9-23.7) (59.3% amoxicillin and 17.8% broad spectrum). Prescribing proportions dropped significantly for nonserious (45.6% to 20.9%) and increased for serious infections (64.1% to 69.8%). Proportions significantly dropped for acute suppurative otitis media (74.7% to 64.1%), upper respiratory tract infections (44.9% to 16.6%), bronchitis/bronchiolitis (73.6% to 44.1%) and acute tonsillopharyngitis (59.5% to 21.7%), while significantly increasing for pneumonia (65.2% to 80.2%). Nonserious and serious infection incidence rates increased from 785/1000PY and 34.2/1000PY to 1223/1000PY and 64.1/1000PY, respectively. Blood and CRP testing proportions increased significantly. CONCLUSIONS: Antibiotic prescribing in general practice for children declined from 2002 to 2022. Further targeted antibiotic stewardship initiatives are needed to reduce the use of broad-spectrum antibiotics and antibiotic prescribing for conditions such as otitis media and bronchitis/bronchiolitis.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Burvenich R, De Boodt S, Lowie L, et al. Temporal trends in antibiotic prescribing and serious and nonserious infections in children presenting to general practice: a registry-based longitudinal cohort study of 162 507 individuals. J Antimicrob Chemother. 2024. PMID: 38714502. doi:10.1093/jac/dkae117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。